Cargando…
Nusbiarylins Inhibit Transcription and Target Virulence Factors in Bacterial Pathogen Staphylococcus aureus
The emergence of multidrug resistance in the clinically significant pathogen Staphylococcus aureus is a global health burden, compounded by a diminishing drug development pipeline, and a lack of approved novel antimicrobials. Our previously reported first-in-class bacterial transcription inhibitors...
Autores principales: | Chu, Adrian Jun, Qiu, Yangyi, Harper, Rachel, Lin, Lin, Ma, Cong, Yang, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461214/ https://www.ncbi.nlm.nih.gov/pubmed/32796751 http://dx.doi.org/10.3390/ijms21165772 |
Ejemplares similares
-
HPLC, quantitative NMR and HRMS spectroscopic data of nusbiarylins as a new class of antimicrobial agents
por: Qiu, Yangyi, et al.
Publicado: (2020) -
Pathogenicity and virulence of Staphylococcus aureus
por: Cheung, Gordon Y. C., et al.
Publicado: (2021) -
Loratadine inhibits Staphylococcus aureus virulence and biofilm formation
por: Zheng, Jinxin, et al.
Publicado: (2022) -
Ligand-Based Drug Design of Novel Antimicrobials against Staphylococcus aureus by Targeting Bacterial Transcription
por: Ye, Jiqing, et al.
Publicado: (2022) -
Biogeography and Virulence of Staphylococcus aureus
por: Fan, Juan, et al.
Publicado: (2009)